Secteur AlzeCure Pharma AB

Actions

ALZCUR

SE0010133785

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Stockholm 18:00:00 27/07/2026 Varia. 5j. Varia. 1 janv.
6,400 SEK +1,91% Graphique intraday de AlzeCure Pharma AB +2,56% +220,00%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+1,91%+2,56%+62,85%+358,78%+220,00%+120,69%+25,00%-36,63% - 89,28 M
-1,82%+4,80%+0,69%+16,63%+10,18%+56,71%+68,36%+214,54%+6 022,48% 57,28 Md
-0,27%+0,35%+5,48%+24,02%+37,53%+40,26%+79,88%-13,79% - 54,99 Md
-2,05%-2,14%+1,31%-22,98%-39,82%+0,75%+413,38%+339,86%+821,92% 23,18 Md
+1,97%-1,16%-0,14%-10,75%-4,32%-21,00%-13,25%-67,93% - 22,59 Md
-0,05%-0,46%+9,52%+14,66%+22,90%+20,75%-10,76%-67,56% - 20,46 Md
+1,57%+3,30%+12,10%+11,78%-5,87%+28,01%-29,07%-30,74%+59,93% 17,56 Md
-1,95%-1,56%+15,59%+7,31%+28,38%+31,81%+544,27% - - 15,67 Md
+5,29%+1,70%+14,77%+118,74%+182,04%+185,09%+333,94%+1 534,49%+726,43% 14,46 Md
+0,79%+0,50%+1,90%+24,99%+27,33%+22,39%+184,74%+235,20%+537,10% 13,92 Md
+1,24%+2,90%+7,53%+5,99%-5,34%+84,74%+175,74%+544,21%+7 250,00% 12,55 Md
-0,08%+19,37%+8,42%+16,21%+28,83%+443,39%+138,71%+29,69%+1 323,13% 12,06 Md
-2,99%+1,11%+4,36%-29,88%-15,35%-36,49%+122,70%+100,95% - 11,69 Md
-0,15%+1,91%-1,91%+30,88%+26,88%+116,84%+150,14%+186,80%+678,19% 10,96 Md
-4,06%-2,93%-6,46%-40,75%-25,07%-54,29%+579,02%+73,12%+83,29% 10,9 Md
-2,05%+2,78%+13,82%+39,14%+205,37%+462,34%+613,68%-39,64%-14,86% 8,98 Md
+0,14%-0,02%+128,47%+117,12%+80,13%+170,57%+354,23%+374,80% - 8,83 Md
-1,63%-1,12%+5,71%-19,38%+17,01%+22,28%+77,74%-6,49% - 8,42 Md
+1,64%-4,88%+29,67%+32,92%+16,37%+26,04%+332,70%+328,57% - 7,92 Md
+1,54%0,00%-1,80%-7,07%+20,29%+51,52%+20,05%+152,85% - 7,89 Md
Moyenne -0,05%+2,43%+15,59%+34,42%+41,37%+88,62%+208,06%+202,75%+1 748,76% 17,02 Md
Moyenne pondérée par Capi. -0,32%+2,16%+8,66%+16,04%+25,20%+66,25%+170,82%+182,73%+2 739,70%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action ALZCUR
  4. Secteur AlzeCure Pharma AB